Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serlopitant in Prurigo Nodularis
NCT02196324Phase 2Completed
- Sponsor
- Vyne Therapeutics
- Start
- Jul 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of serlopitant in prurigo nodularis (PN), sponsored by Vyne Therapeutics. Started Jul 2014; status: completed.
02
Drugs
serlopitant
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on NCT02196324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02196324.